PG
Pendal Group’s Edwards Lifesciences EW Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,791
| Closed | -$203K | – | 583 |
|
|
2021
Q3 | $203K | Buy |
+1,791
| New | +$203K | ﹤0.01% | 559 |
|
|
2021
Q1 | – | Sell |
-2,390
| Closed | -$218K | – | 562 |
|
|
2020
Q4 | $218K | Buy |
+2,390
| New | +$218K | ﹤0.01% | 498 |
|
|
2020
Q3 | – | Sell |
-6,681
| Closed | -$462K | – | 460 |
|
|
2020
Q2 | $462K | Sell |
6,681
-761
| -10% | -$52.6K | 0.01% | 332 |
|
|
2020
Q1 | $1.4M | Buy |
+7,442
| New | +$1.4M | 0.02% | 187 |
|
|
2019
Q4 | – | Sell |
-331
| Closed | -$72.8K | – | 465 |
|
|
2019
Q3 | $72.8K | Sell |
331
-3,651
| -92% | -$803K | ﹤0.01% | 437 |
|
|
2019
Q2 | $736K | Buy |
3,982
+1,170
| +42% | +$216K | 0.01% | 312 |
|
|
2019
Q1 | $538K | Hold |
2,812
| – | – | 0.01% | 354 |
|
|
2018
Q4 | $431K | Buy |
+2,812
| New | +$431K | 0.01% | 340 |
|